Héloïse Lavoie-Gagnon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Héloïse Lavoie-Gagnon has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin Mou
Division of Radiation Oncology, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada; Department of Radiation Oncology, BC Cancer Kelowna, Kelowna, British Columbia, Canada
1 shared publication David Kim
Department of Radiation Oncology, Faculty of Medicine, University of British Columbia, Vancouver, Canada
1 shared publication- Emily Adams
Faculty of Medicine, University of Toronto, Toronto, Canada
1 shared publication - Farhana Islam
Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada
1 shared publication Michael Humer
Division of Thoracic Surgery, Department of Surgery, University of British Columbia, Kelowna, Canada
1 shared publication- Siavash Atrchian
University of British Columbia, 2329 West Mall, Vancouver, BC V6T 1Z4, Canada; BC Cancer - Kelowna, 399 Royal Avenue, Kelowna, BC V1Y 5L3, Canada
1 shared publication
Latest Publications
- 18 April 2025
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 56 (1) , 1-11
Effects of Palliative Esophageal External Beam Radiation Therapy in Patients with Stent for Esophageal Cancer: A Retrospective Cohort Study
Purpose Self-expandable metallic stents (SEMS) provide immediate but nondurable dysphagia relief in esophageal cancer, while external beam radiotherapy (EBRT) provides slower, more durable dysphagia relief. While the combination of SEMS with EBRT would seem to offer both rapid and durable dysphagia relief in the palliative setting, there remains controversy on its safety and efficacy. We investigated patient outcomes regarding EBRT after SEMS placement in patients with incurable esophageal cancer at a regional Canadian cancer program. Methods We conducted a single-centre retrospective chart review from January 2010 to July 2020 to compare stent-related complications and survival in patients with incurable esophageal cancer treated with SEMS alone or SEMS + EBRT at Kelowna General Hospital. Results 66 patients were included in the SEMS alone group and 26 in the SEMS + EBRT group. Patients treated with SEMS alone showed an average of 3.05 fewer stent-related complications compared to patients who received SEMS + EBRT. The SEMS alone group also had 9.05 greater odds of experiencing higher grade complications compared to the SEMS + EBRT group (p < 0.001). Patients in the SEMS + EBRT group survived significantly longer than those treated with SEMS alone, with a median overall survival of 163.5 days and 65 days, respectively. Conclusions SEMS monotherapy was associated with significantly fewer, yet higher grade stent-related complications compared to palliative EBRT after SEMS placement. SEMS + EBRT treatment was associated with significantly prolonged survival compared to SEMS alone. Prospective studies are needed to confirm these findings.
- 18 April 2025
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 56 (1) , 1-11
Effects of Palliative Esophageal External Beam Radiation Therapy in Patients with Stent for Esophageal Cancer: A Retrospective Cohort Study
Purpose Self-expandable metallic stents (SEMS) provide immediate but nondurable dysphagia relief in esophageal cancer, while external beam radiotherapy (EBRT) provides slower, more durable dysphagia relief. While the combination of SEMS with EBRT would seem to offer both rapid and durable dysphagia relief in the palliative setting, there remains controversy on its safety and efficacy. We investigated patient outcomes regarding EBRT after SEMS placement in patients with incurable esophageal cancer at a regional Canadian cancer program. Methods We conducted a single-centre retrospective chart review from January 2010 to July 2020 to compare stent-related complications and survival in patients with incurable esophageal cancer treated with SEMS alone or SEMS + EBRT at Kelowna General Hospital. Results 66 patients were included in the SEMS alone group and 26 in the SEMS + EBRT group. Patients treated with SEMS alone showed an average of 3.05 fewer stent-related complications compared to patients who received SEMS + EBRT. The SEMS alone group also had 9.05 greater odds of experiencing higher grade complications compared to the SEMS + EBRT group (p < 0.001). Patients in the SEMS + EBRT group survived significantly longer than those treated with SEMS alone, with a median overall survival of 163.5 days and 65 days, respectively. Conclusions SEMS monotherapy was associated with significantly fewer, yet higher grade stent-related complications compared to palliative EBRT after SEMS placement. SEMS + EBRT treatment was associated with significantly prolonged survival compared to SEMS alone. Prospective studies are needed to confirm these findings.